The number of dendritic cells per tumor area was significantly higher in EBVaGC cases than in EBV-negative GC cases for any of the DC markers (Figure 5, p < 0.001 for Langerin, CD1a, CD83, CD86, and BDCA-2, and p < 0.05 for S100, respectively, determined by using a Wilcoxon rank sum test). This evidence concerns the gene CD86 and gastric cancer.